Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience.
Molecular Gate has raised $526K in total funding. The most recent round was Seed. The last funding was announced in March 2026.
Molecular Gate's investors include CDTI Innovación's INNVIERTE program, BeAble Capital.
Molecular Gate is headquartered in Barcelona, Spain.
Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience.
Molecular Gate is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Molecular Gate — Funding & Investors." VCBacked, March 2, 2026, https://www.vcbacked.co/company/molecular-gate. Accessed July 21, 2026.
VCBacked. (2026). Molecular Gate — Funding & Investors. Retrieved July 21, 2026, from https://www.vcbacked.co/company/molecular-gate
{{cite web |title=Molecular Gate — Funding & Investors |url=https://www.vcbacked.co/company/molecular-gate |website=VCBacked |access-date=July 21, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated